Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center

Abstract Background Tenecteplase (TNK) offers promising efficacy and safety data for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) and pharmacological advantages over alteplase (rt-PA), justifying its gradual adoption as primary thrombolytic agent. At our tertiary care center, we tra...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Alexander Sekita, Gabriela Siedler, Jochen A. Sembill, Manuel Schmidt, Ludwig Singer, Bernd Kallmuenzer, Lena Mers, Anna Bogdanova, Stefan Schwab, Stefan T. Gerner
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2025-05-01
Reeks:	Neurological Research and Practice
Onderwerpen:	Ischemic stroke Intravenous thrombolysis Tenecteplase Alteplase Procedure times Delayed time window
Online toegang:	https://doi.org/10.1186/s42466-025-00388-x
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!